Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]

INTRODUCTION: The aim of this study was to assess the efficacy of two dosing schedules of recombinant human erythropoietin (rHuEPO) in increasing haematocrit (Hct) and haemoglobin (Hb) and reducing exposure to allogeneic red blood cell (RBC) transfusion in critically ill patients. METHOD: This was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgopoulos, Dimitris, Matamis, Dimitris, Routsi, Christina, Michalopoulos, Argiris, Maggina, Nina, Dimopoulos, George, Zakynthinos, Epaminondas, Nakos, George, Thomopoulos, George, Mandragos, Kostas, Maniatis, Alice
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297615/
https://www.ncbi.nlm.nih.gov/pubmed/16277712
http://dx.doi.org/10.1186/cc3786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297615/
https://www.ncbi.nlm.nih.gov/pubmed/16277712
http://dx.doi.org/10.1186/cc3786

Ejemplares similares